What is the advantage of using monoclonal antibodies in research?

What is the advantage of using monoclonal antibodies in research?

• A. They are less expensive
• B. They are highly specific to a single antigen
• C. They exhibit greater stability
• D. They can be made from any cell type

Answer: (B)

The advantage of using monoclonal antibodies in research lies in their high specificity to a single antigen. Monoclonal antibodies are produced from a single clone of B lymphocytes, which means they are tailored to recognize and bind to one specific epitope of an antigen. This unique characteristic makes them invaluable in various applications, such as diagnostic tests and therapeutic interventions, as they can target substances with great precision, minimizing cross-reactivity with other antigens. In contrast, the other options do not accurately represent the fundamental strength of monoclonal antibodies. While cost and stability can vary with production methods and specific applications, their unparalleled specificity remains their primary benefit in immunological research and application. Monoclonal antibodies can, in fact, be produced from a specific cell type (typically hybridomas), and not from just any cell type, reinforcing the idea that specificity is a cornerstone advantage in their use.

The advantage of using monoclonal antibodies in research lies in their high specificity to a single antigen. Monoclonal antibodies are produced from a single clone of B lymphocytes, which means they are tailored to recognize and bind to one specific epitope of an antigen. This unique characteristic makes them invaluable in various applications, such as diagnostic tests and therapeutic interventions, as they can target substances with great precision, minimizing cross-reactivity with other antigens.

In contrast, the other options do not accurately represent the fundamental strength of monoclonal antibodies. While cost and stability can vary with production methods and specific applications, their unparalleled specificity remains their primary benefit in immunological research and application. Monoclonal antibodies can, in fact, be produced from a specific cell type (typically hybridomas), and not from just any cell type, reinforcing the idea that specificity is a cornerstone advantage in their use.